Preparing the published article.
Company Profile: CYBERDYNE, INC.
A public-source profile of CYBERDYNE covering Medical HAL, wearable robotics, country-specific device scope, dated international implementation and institutional access.
Company and wearable robotics focus
CYBERDYNE, INC. is based in Tsukuba, Ibaraki, Japan, and develops technologies under its Cybernics approach to human-machine interaction. HAL is its wearable robotics family. The company publishes separate medical and non-medical product categories, so the HAL name alone does not identify a regulated medical device or its intended use. A rehabilitation procurement brief should begin with the exact model and clinical setting. Company focus; Corporate location; Product families.
How HAL supports movement
HAL uses sensors on the skin to detect faint bioelectrical signals associated with intended movement. The company's explanation describes using those signals to support joint movement. This is a form of wearable assistance linked to the user's activity; it should not be described as mind reading or as a robot independently deciding a treatment. The required signals, fit and operating method must be evaluated for the selected device and user. HAL operating principle.
Medical HAL and other HAL types
The official catalog separates Medical HAL Lower Limb and Medical HAL Single Joint from well-being versions and lumbar devices for well-being or labor support. A labor-support unit is therefore not automatically interchangeable with a gait-training medical system. Likewise, a permission or study concerning one HAL type should not be assigned to the entire family. Medical and non-medical categories.
The Medical HAL lower-limb page lists multiple sizes and model codes. It notes that suitability depends on body dimensions, not height alone, and describes a monitor showing device and wearer-related information. Buyers should confirm the complete fitting range and the peripherals supplied in the proposed package. Lower-limb models and fitting.
Device and country-specific regulatory scope
The FDA's K233695 record concerns Medical HAL Lower Limb Type. Its indications specify gait training with body-weight support, alongside regular physiotherapy, for defined neurological populations with sufficient residual hip and knee function to trigger and control the device. The record describes use inside healthcare facilities under trained medical supervision, and excludes sports and stair climbing. It is not permission for unrestricted everyday mobility. FDA device record and indications.
CYBERDYNE's European summary separately identifies HAL-ML07 and HAL-ML08 configurations under the EU Medical Device Regulation. Its country-specific documentation should be matched to the proposed model, patient population and setting rather than combining all listed indications into a worldwide claim. European model summary.
Dated international implementation examples
On June 17, 2026, CYBERDYNE reported that Malaysia's PERKESO center in Ipoh had opened the previous day and commenced operations following an agreement covering 50 sets comprising 65 HAL units. The release identifies lower-limb, single-joint and lumbar types. Those 65 units should not be presented as 65 identical medical gait-training systems. The account is manufacturer-reported deployment information, not an independent clinical evaluation. PERKESO opening and equipment scope.
A January 14, 2026 announcement described collaboration with Thailand's Institute of Geriatric Medicine, including clinical and personnel development around lumbar HAL. This agreement records planned collaboration; it does not establish a completed nationwide rollout or approval across ASEAN. Thailand collaboration.
Clinical implementation and evaluation questions
CYBERDYNE requires healthcare professionals using Medical HAL to complete structured safety training with instruction and practical sessions. The implementation plan should include device fitting, supervision, supporting equipment and staff availability. Education requirements.
Which model and local indications match the intended clinical program?
How will the clinical team assess fit, residual movement and suitability?
Which body-weight support, treadmill or other peripherals are required and included?
What operator training, session documentation and outcome measurement will be used?
Who supplies maintenance, cleaning guidance, consumables, software updates and replacement equipment?
Institutional access and official contact
CYBERDYNE's contact page states that Medical HAL and its peripherals are available for rental to medical institutions. It separates product inquiries from patient-service inquiries. An institutional request should specify the country, facility, clinical department, model, expected activity and intended start date. Confirm local rental availability, service responsibility and the full package in writing; the form does not promise supply in every selected country. Institutional contact and rental boundary.
Evidence limits and buyer resources
Regulatory documents define specific device scopes, while product pages and deployment releases describe the supplier's offering. They do not guarantee functional recovery or establish that every HAL product has the same authorization. Patient selection and clinical decisions belong to qualified professionals using current local instructions. Procurement should distinguish institutional equipment access from access to an individual treatment service. Device-use boundaries; Access routes.
Continue with Medical and Rehabilitation Robotics, Write a Robotics Buyer Brief or Robotics RFQ.